首页> 外文期刊>Revista Brasileira de Anestesiologia >A prospective, randomized, double-blinded control study on comparison of tramadol, clonidine and dexmedetomidine for post spinal anesthesia shivering
【24h】

A prospective, randomized, double-blinded control study on comparison of tramadol, clonidine and dexmedetomidine for post spinal anesthesia shivering

机译:前瞻性,随机,双盲对照研究,比较曲马多,可乐定和右美托咪定对脊髓麻醉后抽搐的作用

获取原文
           

摘要

Introduction Shivering, a common intraoperative problem under spinal anesthesia increases the oxygen consumption considerably and is uncomfortable and distressing to the patient, anesthesiologist as well as surgeon. The present study was designed to explore the effectiveness of tramadol, clonidine and dexmedetomidine in the treatment of post spinal anesthesia shivering and to look for their adverse effects. Methods This prospective, randomized, double blinded control study was done on 90 patients who developed shivering under spinal anesthesia. They were randomly allocated into three groups with Group T receiving tramadol 1 mg.kg -1 , Group C getting clonidine 1 mcg.kg -1 and Group D patients receiving dexmedetomidine 0.5 mcg.kg -1 . The time taken to control shivering, recurrence rate, hemodynamic variables, sedation score and adverse effects were observed. Results Dexmedetomidine was faster in the control of shivering in 5.7 ± 0.79 minutes (min) whereas tramadol took 6.76 ± 0.93 min and clonidine was slower with 9.43 ± 0.93 min. The recurrence rate was much lower in the dexmedetomidine group with 3.3% than for clonidine (10%) and tramadol (23.3%) group. The sedation achieved with dexmedetomidine was better than clonidine and tramadol. The tramadol group had more cases of vomiting (four) and dexmedetomidine group had six cases of hypotension and two cases of bradycardia. Two of the clonidine patients encountered bradycardia and hypotension. Conclusion Dexmedetomidine is better than tramadol and clonidine in the control of shivering because of its faster onset and less recurrence rate. Though complications are encountered in the dexmedetomidine group, they are treatable.
机译:简介颤抖是脊柱麻醉下常见的术中问题,大大增加了耗氧量,给患者,麻醉师和外科医生带来不适和困扰。本研究旨在探讨曲马多,可乐定和右美托咪定在治疗脊髓麻醉后瑟瑟发抖中的功效,并探讨其不良反应。方法这项前瞻性,随机,双盲对照研究是对90例在脊髓麻醉下发抖的患者进行的。他们被随机分为三组,T组接受曲马多1 mg.kg -1,C组接受可乐定1 mcg.kg -1,D组接受右美托咪定0.5 mcg.kg -1。观察控制颤抖的时间,复发率,血液动力学变量,镇静分数和不良反应。结果右美托咪定在5.7±0.79分钟(分钟)的颤抖控制中更快,而曲马多花了6.76±0.93分钟,可乐定慢了9.43±0.93分钟。右美托咪定组(3.3%)的复发率比可乐定(10%)和曲马多(23.3%)组低得多。右美托咪定的镇静作用优于可乐定和曲马多。曲马多组呕吐较多(4例),右美托咪定组低血压6例,心动过缓2例。可乐定患者中有2例出现心动过缓和低血压。结论右美托咪定起效快,复发率低,在控制发抖方面优于曲马多和可乐定。尽管右美托咪定组遇到了并发症,但可以治愈。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号